United States:
No (Expensive) Lunch For You! New NJ Regulation Caps Payments To Doctors
08 February 2018
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
Last month, New Jersey joined several other states in adopting a
new regulation limiting payments and gifts that can be made by
pharmaceutical manufacturers to health care providers. The
regulation caps include a maximum of $10,000 per calendar year for
a prescriber's bona fide services, and $15 per meal.
Additional information about this new regulation is available in
our
client alert, or by contacting one of the authors.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
